INTRODUCTION {#SEC1}
============

RNA decay is a crucial process for coordinating prokaryotic gene expression. In gram-positive bacteria, RNase J1, RNase J2 and RNase Y are thought to be major contributors to mRNA degradation and maturation ([@B1]--[@B6]). Two different models of RNA decay have been described: RNA decay can be triggered by pyrophosphohydrolase (RppH), which removes the pyrophosphate from the 5΄ end of triphosphorylated RNA transcripts. The monophosphorylated RNA can then be processed via the exoribonuclease activity of RNase J1 ([@B7]). Degradation can also be initiated via the so-called direct entry pathway, starting with endonucleolytic cleavage. RNA decay continues via the 5΄ to 3΄ exoribonuclease activity of RNase J1 and the 3΄ to 5΄ exoribonuclease activity of PNPase. Initiation by endolytic cleavage is likely to be the major pathway of mRNA decay. For *Bacillus subtilis*, RNase Y has been proposed to be the enzyme responsible for endonucleolytic cleavage of bulk mRNAs ([@B8]--[@B10]) and thus the functional equivalent of *Escherichia coli* RNase E.

Analyses of RNase Y function in *Staphylococcus aureus* revealed that, at least in this organism, RNase Y activity is kept under tight control ([@B11],[@B12]). RNase Y mutants in *S. aureus* are only slightly impaired in growth and only ∼100 cleavage sites were identified using whole-genome analysis ([@B12]). However, RNase Y has been shown to be required for virulence gene expression at the promoter level ([@B11]) and *rny* deletion mutants exhibit reduced virulence ([@B11],[@B13]). To date, it is largely unclear how the activation of virulence genes is mediated by RNase Y. Several non-coding RNAs and the primary transcript of the regulatory *saePQRS* operon were found to be processed by RNase Y ([@B11],[@B12]). RNase Y-mediated processing of these RNA species is probably important for the coordinated expression of virulence genes.

The *saePQRS* operon encodes four different proteins. SaeR and SaeS are part of a bacterial two-component system with a response regulator and a histidine kinase that control the expression of major virulence genes in *S. aureus* ([@B14]--[@B16]). The functions of SaeP and SaeQ are not clear. It has been suggested that these two proteins assist the activated Sae system to return to its pre-stimulus state ([@B17]--[@B19]). The *sae* operon (Figure [1A](#F1){ref-type="fig"}) is transcribed from two promoters (P1 and P3) and a total of four overlapping RNAs (T1--T4) are detectable. The mature T1 transcript is transcribed from the major auto-activated P1 promoter. The most abundant and stable T2 RNA is generated by RNase Y-dependent endoribonucleolytic cleavage of T1 ([@B11],[@B20]). T3 is transcribed from the constitutive P3 promoter to ensure a basal level of *saeRS* expression. T4 is also initiated at the P1 promoter but encompasses a monocistronic RNA encoding only *saeP*. T4 may be either a processed product of T1 or a prematurely terminated *de novo* transcript from P1 ([@B14],[@B21]).

![RNase Y allows differential expression between genes co-expressed in the *saePQRS* operon. (**A**) Schematic representation of the *saePQRS* operon, with its primary and mature RNA molecules (T1--T4), promoters (P1 and P3), terminator (Term), cleavage site (CS) and putative stem loops. (**B**) Schematic representation of *sae-gfp* constructs carrying different deletions (the deleted sequence is indicated in the panel with a cross). The RNAs observed in the northern blot analyses are indicated with their names and lengths below each constructs. (**C**) Northern blot analyses to examine *sae* processing in strains carrying the *sae-gfp* constructs. Newman *saeP* mutant and *saeP rny* double mutant strains carrying different constructs were grown to exponential phase. RNA was then harvested and hybridized with DIG-labeled DNA probes specific for *gfp, saeP* and *rny*. As a loading control, 16S rRNA detected in the ethidium bromide-stained gel was used, which is shown at the bottom of the panel. For clarity, lane numbers are indicated in the panel. (**D**) RT-qPCR to assess the ratio between *saeR* and *saeP* copy numbers. Newman wild-type, *rny* mutant and complemented strains were grown (in triplicate) to late exponential phase and RNA was extracted. After DNase I treatment, one-step RT-qPCR was performed. *saeR* and *saeP* copy numbers were calculated by reference to a standard curve. Statistically significant differences between the samples are indicated: \*\**P* = 0.001 to 0.01; \*\*\**P* \< 0.001.](gkx296fig1){#F1}

RNase Y in *B. subtilis* is an integral part of the degradosome, which also contains RNase J1, RNase J2, enolase and the CshA helicase. RNase Y is the only protein in the complex with a membrane anchor and is thought to function as a scaffold for the entire machinery ([@B9],[@B22],[@B23]). For *B. subtilis*, it has been postulated that an RNase Y membrane anchor is required for function *in vivo* ([@B9]). The presence of a degradosome-like complex in *S. aureus* has also been suggested ([@B24]). However, the RNase Y of *S. aureus* does not seem to be the key enzyme for complex formation because it does not participate in many protein interactions ([@B24]). For RNase Y of *S. aureus*, RNase Y membrane association appears to be required to limit activity and for the further selectivity of RNase Y *in vivo* ([@B12],[@B25]).

Our understanding of the structure, enzymatic activity and sequence requirements of RNase Y is still in its infancy. In a recent study, a novel global method called EMOTE (Exact Mapping Of Transcriptome Ends) ([@B26]) was used to explore the *in vivo* recognition sequence motif of RNase Y ([@B12]). The authors identified a preferred target sequence (a guanosine immediately prior to the cleavage site) ([@B12]).

Only a few studies have reported findings for purified RNase Y. RNase Y lacking the N-terminal membrane anchor from *B. subtilis* ([@B8]) has been shown to exert endonucleolytic activity of *in vitro*-transcribed 5΄ monophosphorylated RNAs. Purified RNase Y from *S. aureus* cleaves the 2΄-3΄-cyclic phosphodiester linkage at the 3΄ terminus ([@B27]). The generated 3΄ monophosphorylated RNA seems to be protected from PNPase exonucleolytic degradation ([@B28]). However, the *in vitro* results are inconsistent with the *in vivo* assays. For example, the preference for 5΄ monophoshorylated RNA could not be confirmed *in vivo* ([@B29]), and the products generated by RNase Y are readily degraded by PNPase ([@B30]). Thus, it appears that the native function of the enzyme cannot be easily mirrored using *in vitro* assays.

The aim of this work was to elucidate the sequence/structural requirements of RNase Y-dependent processes *in vivo*. The *saePQRS* operon was chosen as the model RNA because it contains one of the best defined RNase Y processing sites. At least one cleavage product is stabilized and thus easily detectable ([@B11],[@B12][@B20]). Here it is shown that in contrast to the downstream fragment, the RNase Y-generated upstream fragment is rapidly degraded. This result implies that RNase Y allows differential expression of genes that are co-expressed from the same operon. Cloning analysis revealed that RNase Y cleavage was not determined by the sequence of the cleavage site. A 24-bp double-stranded recognition structure could be identified that was required to initiate cleavage 6 nt upstream.

MATERIALS AND METHODS {#SEC2}
=====================

Bacterial strains and growth conditions {#SEC2-1}
---------------------------------------

The strains used in this study are listed in Table [1](#tbl1){ref-type="table"}. *S. aureus* strains were grown in CYPG medium (10 g l^−1^ casamino acids, 10 g l^−1^ yeast extract, 5 g l^−1^ NaCl, 0.5% w/v glucose and 0.06 M phosphoglycerate) ([@B31]). For strains carrying resistance genes, antibiotics were used only in overnight cultures at the following concentrations: 10 μg ml^−1^ erythromycin, 5 μg ml^−1^ tetracycline and 10 μg ml^−1^ chloramphenicol. Bacteria from overnight cultures were diluted to an initial optical density at 600 nm (OD600) of 0.05 in fresh medium and grown with shaking at 220 rpm at 37°C to exponential growth phase.

###### Bacterial strains and plasmids

  Strain or plasmid                  Description                                                                                                                                                                                                      Reference
  ---------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------
  **Strains**                                                                                                                                                                                                                                         
  ***E. coli***                                                                                                                                                                                                                                       
  TOP10                              Competent *E. coli* for plasmid transformation                                                                                                                                                                   Invitrogen
  DC10B                              Competent *E. coli* for direct plasmid transformation into clinical isolates of *S. aureus*                                                                                                                      [@B46])
  BL21 (DE3)                         *E. coli* for expression of recombinant proteins with IPTG                                                                                                                                                       Promega
  ***S. aureus***                                                                                                                                                                                                                                     
  ISP479C                            8325-4 derivative, with SaeS^L^ allele                                                                                                                                                                           ([@B47])
  CYL316                             RN4220(*pYL112Δ19*), L54 *int* gene,                                                                                                                                                                             ([@B34])
  RN4220                             Restriction-deficient *S. aureus* strain                                                                                                                                                                         ([@B48])
  RN4220-30                          RN4220 *saeP::kanA*                                                                                                                                                                                              This work
  RN4220-217                         RN4220 *rny*::*ermC*                                                                                                                                                                                             ([@B11])
  Newman                             Wild-type                                                                                                                                                                                                        ([@B49])
  Newman-29                          Newman, *sae::kanA*                                                                                                                                                                                              ([@B20])
  Newman-30                          Newman *saeP::kanA*                                                                                                                                                                                              This study
  Newman-217                         Newman *rny*::*ermC*                                                                                                                                                                                             ([@B11])
  Newman-217-30                      Newman *rny*::*ermC, saeP::kanA*                                                                                                                                                                                 This work
  PR01                               *ΔpyrFE* mutant of the clinical strain SA564RD                                                                                                                                                                   ([@B39])
  PR01-01                            PR01 with the RNase J1 gene deleted                                                                                                                                                                              ([@B39])
  **Plasmids**                                                                                                                                                                                                                                        
  **For SaeP mutant construction**                                                                                                                                                                                                                    
  pMAD                               Vector for allelic replacement                                                                                                                                                                                   ([@B33])
  pBT2                               Cloning vector                                                                                                                                                                                                   ([@B31])
  pCWsae30                           pMAD with cloned *saeP::kanA*                                                                                                                                                                                    This study
  **For PCR template**                                                                                                                                                                                                                                
  pCWsae19                           pCR2.1-Topo with *saePQRS* with stop codon in *saeP*                                                                                                                                                             (T. Geiger, unpublished)
  **Integrative plasmids**                                                                                                                                                                                                                            
  pCG188                             pCL84 with truncated *gfp* gene cassette from pc183                                                                                                                                                              ([@B11])
  pCG212                             pCG188 with *sae* region from P1 to upstream of P3                                                                                                                                                               ([@B11])
  pCG213                             pCG188 with *sae* region from P1 to upstream of P3 with deletion of 13 bp in the CS                                                                                                                              This work
  pCG218                             pCG188 with *sae* region from P1 to upstream of P3 with deletion of the left stem loop (terminator)                                                                                                              This work
  pCG219                             pCG188 with *sae* region from P1 to upstream of P3 with deletion of the right stem loop                                                                                                                          This work
  pCG223                             pCG188 with *sae* region from P1 to upstream of P3 with deletion of the entire region between the two stem loops                                                                                                 This work
  pCG379                             pCG188 with *sae* region from P1 to upstream of P3 with deletion of the two stem loops                                                                                                                           This work
  pCG301                             pCG188 with *sae* region between the 2 stem loops under the native P1 promoter                                                                                                                                   This work
  pCG392                             pCG188 with *sae* region from P1 to upstream of P3 with deletion of the sequence downstream of CS (Rrs)                                                                                                          This work
  pCG394                             pCG188 with *sae* region from P1 to upstream of P3 with deletion of the CS and alternative CS (aCS)                                                                                                              This work
  pCG484                             pCG188 with *sae* region from P1 to upstream of P3 with deletion of the Rrs counterpart                                                                                                                          This work
  pCG589                             pCG212 with *sae* region with mutated CS (C instead of T)                                                                                                                                                        This work
  **Replicative plasmids**                                                                                                                                                                                                                            
  pCG246                             *E. coli*/Staphylococcus shuttle vector, pCN47 derivative with *cat* cassette                                                                                                                                    ([@B50])
  pCG599                             pCG246 with *sae-gfp* region from plasmid pCG212                                                                                                                                                                 This work
  pCG600                             pCG246 with *sae-gfp* region from plasmid pCG484                                                                                                                                                                 This work
  pCG601                             pCG246 with *sae-gfp* region from plasmid pCG392                                                                                                                                                                 This work
  pCG616                             pCG246 with *sae-gfp* region from plasmid pCG589                                                                                                                                                                 This work
  pCG618                             pCG599 with *sae* region with point mutation which affect Rrs secondary structure: CC in +3 and +8 instead of AA, CC in +14 and +15 instead of TT (the position is indicated as distance to the cleavage site)   This work
  pCG620                             pCG246 with *sae-gfp* region from plasmid pCG223                                                                                                                                                                 This work
  **For complementation**                                                                                                                                                                                                                             
  pCG296                             pCG246 with *rny* for complementation                                                                                                                                                                            ([@B11])
  pCG322                             pCG246 with *rny* without active site for complementation                                                                                                                                                        This work
  pCG596                             pCG246 with *rny* carrying mutations in the active site (H367A D368A)                                                                                                                                            This work
  **For protein purification**                                                                                                                                                                                                                        
  pET15b                             Protein expression vector, IPTG inducible                                                                                                                                                                        Novagen
  pCG249                             pET15b with *rny* (without transmembrane domain)                                                                                                                                                                 This work

Plasmid and strain construction {#SEC2-2}
-------------------------------

All plasmids and oligonucleotides are listed in Tables [1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}, respectively.

###### Oligonucleotides

  Purpose                                                 Template            Name                     Sequence
  ------------------------------------------------------- ------------------- ------------------------ ------------------------------------------------------------
  ***saeP* deletion mutant**                                                                           
                                                          ISP479C             Kpnsae-for               CGGGGTACCATACTACAGTTTTACATT
                                                                              Kpn-ORF4-rev             ACCTCGGTACCCTGTTCTTACGACCTCTAAAG
                                                                              HybridORF4a-rechts       TAAAAGTTCGCTAGATAGGGGTCCCGCGTATGATTTCACAGCC
                                                                              Hybridsae-links          TCCAATTCTCGTTTTCATACCTCGGAGCTAACTCCTCATTTCTTCAATTT
                                                          Newman29            kanR-for                 CCGAGGTATGAAAACGAGAATTGG
                                                                              kanR-rev                 GGGACCCCTATCTAGCGAACTTT
  ***sae--gfp* fusion in integrative plasmid (pCG188)**                                                
                                                                              Eco-sae-for              GCGTGAATTCTTATTGTGGCAAAAGGTTT
                                                                              Eco-sae1283rev           CGTGAATTCTGACGTCGTATGTGCAACTA
                                                                              Eco-sae1014rev           GGGAATTCTTATGTGAACAGGAAGTGTTT
  control PCRs                                                                gfp-rev-all              GGTATCACCTTCAAACTTGACTT
  pCG213                                                  pcwsae19            DelP2for                 TCAATATATATACCATAAGATTGC
                                                                              DelP2rev                 GCAATCTTATGGTATATATATTGA
  pCG218                                                  pcwsae19            DelST-orf4for            AGAGCACATAAGAAACACTTCCT
                                                                              DelST-orf4rev            AGGAAGTGTTTCTTATGTGCTCT
  pCG219                                                  pcwsae19            DelST5for                TCAATGGAAAGCATATATACAACT
                                                                              DelST5rev                AGTTGTATATATGCTTTCCATTGA
  pCG223                                                  pcwsae19            DelP2longfor             TCAATGGAAAGCAAACACTTCCT
                                                                              DelP2longrev             AGGAAGTGTTTGCTTTCCATTGA
  pCG379                                                  pCG218              DelST5rev                AGTTGTATATATGCTTTCCATTGA
                                                                              DelST5for                TCAATGGAAAGCATATATACAACT
  pCG301                                                  pcwsae19            hybridsaePdelrev         CTTTCCATTGAGTAACCTTGATCTTGTGA
                                                                              hybridsaePdelfor         CACAAGATCAAGGTTACTCAATGGAAAGC
  pCG392                                                  pcwsae19            hybridpCG392rev          TCAAGCTCTAAAAAAATTTAGATTTAATAGTTGTATATAT
                                                                              hybridpCG392for          ATATATACAACTATTAAATCTAAATTTTTTTAGAGCTTGAT
  pCG394                                                  pcwsae19            hybridpCG394rev          TGTGCTCTGCAATCTTATGGATTGAAAAAAGGAAAGTATG
                                                                              hybridpCG394for          CATACTTTCCTTTTTTCAATCCATAAGATTGCAGAGCACA
  pCG484                                                  pcwsae19            Hybrid-Rrs-Counter-rev   CGATTTGTAGTGTTATGTGA
                                                                              Hybrid-Rrs-Counter-for   TCACATAACACTACAAATCGTTTATATAAATTACACACAAT
  pCG589                                                  pCG212              Q5SDMpCG212R             ATATATTGAAAAAAGGAAAGTATGATTTC
                                                                              Q5SDMpCG212F             ATACAACTATCAAATCCCATAAGATTG
  ***sae--gfp* fusion in replicative plasmid (pCG246)**                                                
  pCG599                                                  pCG212              Gibson-saeconstr-for     ATTTAGAATAGGCGCGCCTGAATTCTTATTGTGGCAAAAGGTTTATAAATTTTAATAC
                                                                              Gibson-saeconstr-rev     ATCCCCGGGTACCGAGCTCGAATTCTTACAAACAAAAAGCGGATTAC
  pCG600                                                  pCG484              Gibson-saeconstr-for     ATTTAGAATAGGCGCGCCTGAATTCTTATTGTGGCAAAAGGTTTATAAATTTTAATAC
                                                                              Gibson-saeconstr-rev     ATCCCCGGGTACCGAGCTCGAATTCTTACAAACAAAAAGCGGATTAC
  pCG601                                                  pCG392              Gibson-saeconstr-for     ATTTAGAATAGGCGCGCCTGAATTCTTATTGTGGCAAAAGGTTTATAAATTTTAATAC
                                                                              Gibson-saeconstr-rev     ATCCCCGGGTACCGAGCTCGAATTCTTACAAACAAAAAGCGGATTAC
  pCG616                                                  pCG589              Gibson-saeconstr-for     ATTTAGAATAGGCGCGCCTGAATTCTTATTGTGGCAAAAGGTTTATAAATTTTAATAC
                                                                              Gibson-saeconstr-rev     ATCCCCGGGTACCGAGCTCGAATTCTTACAAACAAAAAGCGGATTAC
  pCG618                                                  pCG599              Q5SDMpCG618F             AAGACCGCAGAGCACATAAGTAAATTTTTTTAG
                                                                              Q5SDMpCG618R             AGGGGAGTTAATAGTTGTATATATATTGAAAAAAGG
  pCG620                                                  pCG223              Gibson-saeconstr-for     ATTTAGAATAGGCGCGCCTGAATTCTTATTGTGGCAAAAGGTTTATAAATTTTAATAC
                                                                              Gibson-saeconstr-rev     ATCCCCGGGTACCGAGCTCGAATTCTTACAAACAAAAAGCGGATTAC
  **RNase Y Complementation**                                                                          
  pCG322                                                  RN6390              RecA-dig-for             GTCAAGGTAAGGAAAATGTT
                                                                              hybrid-Rny-delKD-rev     TGCACCTGGACGAGCTACATTTTGACCGT
                                                                              hybrid-Rny-delKD-for     ACGGTCAAAATGTAGCTCGTCCAGGTGCA
                                                                              SAV1287-rev              AACAATTTGTTGCAATTG
                                                                              BamHI-RNY-for            CCGGATCCGTTAAACTTAGCAAATATCCT
                                                                              EcoRI-RNY-rev            CGAATTCCTCAACTTAGAAATAAATCCTA
  pCG596                                                  pCG296              Q5SDMpCG296R             GCTCGTTTCGCTAATGTC
                                                                              Q5SDMpCG296F             TGGACTTTTAGCTGCTGTTGGTAAAGCAATTGATC
  **Race**                                                                                             
                                                                              RNA 5΄ adapter           CTAGTACTCCGGTATTGCGGTACCCTTGTACGCCTGTTTTATA
                                                                              gfp-rev1                 TCTTTTGTTTGTCTGCCAT
                                                                              Race 2                   Race 2 GTATTGCGGTACCCTTGT
                                                                              gfp-rev-all              GGTATCACCTTCAAACTTGACTT
  **DIG probes**                                                                                       
  *gfp*                                                   pCG188              gfp-dig-for              CACTTGTCACTACTTTCGGTT
                                                                              gfp-dig-rev              TCTCTCTTTTCGTTGGGAT
  *saeP*                                                  RN6390              uorf4358                 TATTATTTGCCTTCATTTTA
                                                                              lorf4616                 ACCTTTTGATGATTTGTAGTTAG
  *rny*                                                   RN6390              SAV1286dig-for           TTATTAGAGAAGCAGGTGAACA
                                                                              SAV1286dig-rev           TCTTCAGGAGATACAATCACTC
  *rny 5 prime*                                           RN6390              RNY-dig-for2             TTCATATAAAGAGCAAACCC
                                                                              RNY-dig-rev2             TTTTGATATTGTCAGCTTCT
  *rnjA*                                                  RN6390              sav1089digfor            CACCGATACCACTACCAT
                                                                              sav1089digrev            ACCTGAAGATACCGTTGT
  **RT-qPCR**                                                                                          
  *saeR standard*                                         Newman              T7sae                    TAATACGACTCACTATAGGGAGAAACTGCCAAAACACAAGA
                                                                              saeR2                    CCATTATCGGCTCCTTTCA
  *saeP standard*                                         Newman              T7-ORF4                  TAATACGACTCACTATAGGGAGACAAATTGAAGAAATGAGGAGTTA
                                                                              lorf4616                 ACCTTTTGATGATTTGTAGTTAG
  *saeR*                                                                      saeR4                    TAGTCATATCCCCAAACTT
                                                                              saeU4                    CCATTTACGCCTTAACTTTA
  *saeP*                                                                      uorf4358                 TATTATTTGCCTTCATTTTA
                                                                              lorf4616                 ACCTTTTGATGATTTGTAGTTAG
  **Protein purification**                                                                             
  pCG249                                                  Newman              Xho-rny-pETfor           GGGGCTCGAGCGAAATTTGTTGCTTCAAAAG
                                                                              Bam-rny-pETrev           GGGGGGATCCTTATTTCGCATATTCTACTGCT
  **Transcripts for RNase Y *in vitro* cleavage assay**                                                
                                                          pCG212 and pCG484   T7saeorf4u               TAATACGACTCACTATAGGGAGACAAATTGAAGAAATGAGGAGTTA
                                                                              LCgfpmut3.1rev1          TCTTTTGTTTGTCTGCCAT

### saeP deletion mutant and saeP rny double mutant {#SEC2-2-1}

Replacement of the *saeP* locus with a kanamycin resistance cassette (*kan*) was achieved by overlapping polymerase chain reaction (PCR). The resulting amplicon was digested with KpnI and cloned into pBT2 ([@B32]). To take advantage of blue-white selection, the fusion fragments were then sub-cloned into the EcoRI and SalI sites of pMAD ([@B33]). The resulting plasmid, pCWSAE30, was verified and transformed into the restriction-deficient strain RN4220, followed by mutagenesis as described previously ([@B33]). The mutant (referred to as RN4220-30) was verified by PCR and pulsed-field gel electrophoresis. The resulting mutation was transduced into Newman, yielding strain Newman-30. The *saeP rny* double mutant (referred to as Newman-217-30) was obtained by transduction of the *rny::ermC* mutation from RN4220-217 ([@B11]) into Newman-30.

### Construction of sae-gfp fusions {#SEC2-2-2}

Construction of the integration plasmids was achieved using pCG188 ([@B11]), which allows plasmid integration into the *geh* locus. Different deletions in the *sae* region spanning the P1 promoter until upstream of the P3 promoter were introduced by overlapping PCR using oligonucleotides and templates listed in Table [2](#tbl2){ref-type="table"}. The amplicons were ligated into the EcoRI-digested pCG188 to generate the various plasmids listed in Table [1](#tbl1){ref-type="table"}. The correct orientation and sequence of the inserts were verified by PCR using a specific upstream oligonucleotide together with gfp-rev-all, and by Sanger sequencing before integration into the lipase gene of competent *S. aureus* CYL316 ([@B34]). The integrated plasmids were subsequently transduced into the appropriate experimental *S. aureus* strains. All transductants were verified by PCR. For cloning of sae-gfp constructs into the replicative plasmid pCG246, the *sae-gfp* region from plasmids pCG212, pCG392, pCG484 and pCG223 was subcloned by Gibson assembly using the oligonucleotides listed in Table [2](#tbl2){ref-type="table"} to generate pCG599, pCG600, pCG601 and pCG620, respectively. The plasmids were verified by Sanger sequencing, cloned into DC10B and then transferred into electro-competent *S. aureus* strains.

### Construction of sae-gfp construct with mutated CS or mutated secondary structure {#SEC2-2-3}

Point mutations were introduced into selective constructs by site-directed mutagenesis (SDM Q5 Kit, New England Biolabs) according to the manufacturer\'s instructions using the oligonucleotides listed in Table [2](#tbl2){ref-type="table"}. The CS (C/T) mutation in the *sae* cleavage site was introduced into plasmid pCG212 to generate plasmid pCG589. The *sae-gfp* region in plasmid pCG589 was then subcloned into the replicative plasmid pCG246 by Gibson assembly using the oligonucleotides listed in Table [2](#tbl2){ref-type="table"} to generate pCG616. Point mutations to prevent secondary structure formation downstream of the CS (Figure [6C](#F6){ref-type="fig"}) were introduced directly into plasmid pCG599 to generate plasmids pCG618. All plasmids were verified by Sanger sequencing, cloned into DC10B and transferred into electro-competent *S. aureus* strains.

### Construction of strains complemented with RNase Y with a deletion or mutations (H367A, D368A) in its active site {#SEC2-2-4}

A 300-bp deletion in the RNase Y active site was introduced by overlapping PCR employing oligonucleotides listed in Table [2](#tbl2){ref-type="table"}. The amplicon was cloned into BamHI/EcoRI-digested pCG246 to generate plasmid pCG322. The H367A and D368A mutations in the RNase Y active site were introduced into plasmid pCG296 by site-directed mutagenesis (SDM Q5 Kit) according to the manufacturer\'s instructions (New England Biolabs) to generate plasmid pCG596. Both plasmids were cloned into *E. Coli* DC10B and then introduced into Newman *rny* mutant.

RNA isolation, northern blot hybridization and quantitative RT-qPCR {#SEC2-3}
-------------------------------------------------------------------

RNA isolation and northern blot analysis were performed as described previously ([@B35]). Briefly, bacteria were lysed in 1 ml of TRIzol reagent (Invitrogen) with 0.5 ml of zirconia-silica beads (0.1 mm diameter) in a high-speed homogenizer. RNA was then isolated as described by the manufacturer. For northern blot analysis, digoxigenin (DIG)-labeled DNA probes for the detection of specific transcripts were generated using a DIG-labeling PCR kit as described by the manufacturer (Roche Life Science) with the oligonucleotides listed in Table [2](#tbl2){ref-type="table"}.

The transcript abundance of *saeR* and *saeP* from three independent experiments was determined by real-time RT-qPCR (run in duplicate) as described previously ([@B36]). Briefly, 5 μg of each RNA sample was treated with DNaseI for 30 min at RT, and the reaction was stopped with a DNase inactivation reagent (Invitrogen). RNA was then diluted 1:10, and one-step qRT-PCR was performed with the amplification kit for SYBR Green (Roche Life Science) using the appropriate oligonucleotides listed in Table [2](#tbl2){ref-type="table"}.

For quantification, sequence-specific RNA transcripts for *saeR* and *saeP* were prepared as previously described ([@B36]). Briefly, gene-specific primers with a 5΄ extension, including the T7 promoter sequence (Table [2](#tbl2){ref-type="table"}), were used for standard PCR. T7-driven *in vitro* transcription was performed using a standard transcription assay (T7-MEGAshortscript; Invitrogen). After DNase I treatment, RNA was recovered using the MEGAclear Kit (Invitrogen), and RNA quantification was performed spectrophotometrically. Purity was verified on denaturating agarose gels and A260/280 ratio. Standard curves of sequence-specific RNA standards were generated by serial dilution (1 × 10^6^, 3.16 × 10^5^, 1 × 10^5^, 3.16 × 10^4^, 1 × 10^4^, 3.16 × 10^3^ and 1 × 10^3^), and the copy numbers of the sample transcripts were calculated with the aid of light cycler 480 software (absolute quantification/2nd derivative max, Roche Life Science). Amplification of *saeP* and *saeR* occurred with an efficiency of 1.85 and 1.89 and an error of 0.012 and 0.011 respectively.

5΄ Rapid amplification of cDNA ends {#SEC2-4}
-----------------------------------

5΄ Rapid amplification of cDNA ends (RACE) was performed as described previously ([@B11]). Briefly, total RNA was isolated and rRNA was removed using MICROBExpress (Invitrogen). A specific RNA 5΄ adapter (Table [2](#tbl2){ref-type="table"}) was then ligated to the RNA. After phenol/chloroform extraction and ethanol precipitation, the RNA was subjected to reverse transcription using oligonucleotide gfp-rev1. Nested PCR was performed using oligonucleotides Race 2 and *gfp*-rev-all (Table [2](#tbl2){ref-type="table"}). The PCR amplicon was detected on a 3% agarose gel, eluted, cloned into pCRII-TOPO (Invitrogen) and sequenced.

Protein purification and *in vitro* assay {#SEC2-5}
-----------------------------------------

### Protein purification {#SEC2-5-1}

To construct the plasmid for the overproduction of RNase Y with N-terminal His-Tag, the coding sequence of the *rny* gene excluding the first 24 residues comprising a putative transmembrane domain was PCR-amplified using the primers listed in Table [2](#tbl2){ref-type="table"}. The amplicon was ligated into XhoI/BamHI-digested pET-11b vector (Novagen), resulting in pCG249. *E. coli* BL21 (DE3) transformed with pCG249 or with an empty plasmid (as control) was grown in Luria-Bertani broth containing 100 μg ml^−1^ ampicillin and 25 μg ml^−1^ chloramphenicol at 37°C to an OD600 of 0.5. Protein expression was induced in both BL21 strains (for RNase Y expression and empty control) with 1 mM IPTG for 2 h. Bacterial cells were harvested by centrifugation and suspended in lysis buffer (100 mM NaH~2~PO~4~, 10 mM Tris, 8 M irea and 10 mM imidazol pH 8). EDTA-free protease inhibitor cocktail (Roche Life Science) and lysozyme (1 mg ml^−1^) were added and the mixture was shaken at room temperature for 30 min. Complete lysis was achieved by sonication. The resulting homogenate was centrifuged at 10000 × *g* for 30 min to pellet the cellular debris. A total of 1 ml of 50% Ni-NTA slurry (Quiagen) was added to 4 ml of lysate and mixed gently by shaking for 60 min. Column purification was then performed following the manufacturer\'s instructions (Quiagen). The eluted fractions were analyzed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis to check for purity. The fractions containing recombinant protein were collected and dialyzed against HEPES 20 mM, NaCl 100 mM, glycerin 30%, MgCl~2~ 1 mM and sodium deoxycholate 0.2% for 24 h at 4°C. Purification procedure was performed in parallel using BL21 with pET-11b and used as control in the activity assays[.]{.ul}

### Enzymatic activity {#SEC2-5-2}

To monitor enzymatic activity, an assay for phosphodiesterase activity against 1 mM bis-pNpp (Roche Life Science) was used, as previously described ([@B27]). Recombinant RNase Y was added to HEPES 20 mM and NaCl 100 mM at pH 8 containing 1 mM MnCl~2~. The chromogenic substrate bis-pNPP (*p*-nitrophenyl phosphate) was added at 1 mM. Reactions were carried out in 100 μl volumes in 96-well microtitre plates at 37°C. Hydrolysis of bis-pNPP was monitored measuring the increase in absorbance at 405 nm with the help of the Infinite 200 ProSeries Reader (Tecan).

### RNase Y cleavage assay {#SEC2-5-3}

Sequence-specific RNA transcripts for constructs pCG212 and pCG484 were prepared by *in vitro* transcription using the primers listed in Table [2](#tbl2){ref-type="table"}. T7-driven *in vitro* transcription was performed in a standard transcription assay (T7-MEGAshortscript). After DNase I treatment, RNA was recovered using the MEGAclear Kit (Invitrogen), and RNA quantification was performed spectrophotometrically. RNase Y cleavage assay was performed using 0.125 μg of RNA substrate and purified 1.36 μM of RNase Y or control dialysate of Bl21, pET-11b cells in a reaction volume of 10 μl (20 mM HEPES pH 8, 100 mM NaCl, 1 mM MnCl~2~ or 8 mM MgCl~2~). The reactions were incubated for 10 min at 30°C. After ethanol precipitation, RNA was dissolved in 10 μl loading buffer (50% formamide, 6.5% formaldehyde, 3 μg ethidiumbromide, in 40 mM 3-(N-morpholino) propanesulfonic acid buffer) and RNA was loaded onto denaturating agarose gel (1% agarose, 1.8% formaldehyde in 40 mM 3-(N-morpholino) propanesulfonic acid buffer). Transcripts were detected by northern blot analysis using *gfp* DIG probes created as described above.

RESULTS {#SEC3}
=======

The monocistronic transcript T4 encoding *saeP* arises via termination {#SEC3-1}
----------------------------------------------------------------------

RNase Y is involved in the processing of the primary T1 transcript of the *sae* operon, which leads to the formation of the stable T2 RNA ([@B11],[@B20]) encoding the response regulator SaeR and the histidine kinase SaeS (Figure [1A](#F1){ref-type="fig"}). This processing event occurs at a CS ([@B11]) that is flanked by two stem loops (Figure [1A](#F1){ref-type="fig"}). Interestingly, the upstream stem loop was previously predicted to be a *rho*-independent terminator ([@B37]). Thus, the small T4 RNA encoding *saeP* could be either a processed product of T1 or generated by premature termination of a *de novo* transcript.

To address this question and to further study the impact of the various structural elements in *sae* processing, the *saePQ* region, including the promoter P1 and carrying different deletions flanking the CS, was fused to a truncated *gfp* gene without a ribosome binding site (Figure [1B](#F1){ref-type="fig"}). A stop codon was introduced into the *saeP* gene to prevent any possible interference of the SaeP protein with transcription. The *sae-gfp* constructs (Figure [1B](#F1){ref-type="fig"}) were integrated into the wild-type strain and the *rny* mutant, in which the native *saeP* was replaced with a *kanA* resistance cassette. This procedure allowed the detection of the artificial RNAs by northern blot analysis using probes lying upstream (*saeP*) and downstream (*gfp*) of the CS without detection of the native *saePQRS* operon (Figure [1C](#F1){ref-type="fig"}).

In the wild-type strain carrying the reference construct pCG212, two bands were detected using both *gfp* and *saeP* probes (Figure [1C](#F1){ref-type="fig"}, lane 1). In both cases, the band with the higher molecular weight corresponded to the unprocessed transcript T1. The bands with lower molecular weights corresponded to T2 in the case of the *gfp* probe and to T4 in the case of the *saeP* probe. In the *rny* mutant carrying different constructs, T2 could not be detected, confirming that RNase Y is involved in the processing and generation of T2 (Figure [1C](#F1){ref-type="fig"}, lanes 7--12, *gfp* panel). However, T4 was also detectable in the *rny* mutant (in which no processing occurs) as long as the proposed terminator structure (the first stem loop in constructs pCG212, pCG213 and pCG218) was present (Figure [1C](#F1){ref-type="fig"}, lanes 7--9, *saeP* panel). In constructs lacking this stem loop (pCG219, pCG379 and pCG223), T4 was neither detectable in the wild-type nor in the mutant strain (Figure [1C](#F1){ref-type="fig"}, lanes 4--6 and 10--12, *sae*P panel). This indicates that T4 arose via premature termination at the *rho*-independent terminator and not from processing of the T1 transcript. Thus, the upstream fragment resulting from RNase Y cleavage is subject to rapid degradation by 3΄ exonuclease activity which is not inhibited by T4 terminator structure (Figure [1C](#F1){ref-type="fig"}, compare lanes 1--3 with lanes 7--9). If the terminator structure was inhibiting the exonuclease activity, one would expect to see more T4 RNA (arising from the combination of transcription termination and RNase Y cleavage followed by chew back till the terminator structure) in the wild-type relative to the *rny* mutant.

Altogether the above findings suggest that, on one hand the upstream fragment resulting from RNase Y cleavage is subjected to rapid degradation. On the other, the downstream fragment (T2) is stabilized ([@B11]). Thus, RNase Y allow differential expression of the genes that are co-expressed in the *saePQRS* operon, which should be reflected by the relatively higher expression of *saeRS* compared to *saeP*. To investigate this hypothesis, we performed qRT-PCR in the Newman wild-type, the *rny* mutant and in the complemented strain with ectopic expression of RNase Y to quantify transcript abundance of *saeR* and *saeP*. P1 and P3 promoter activity in Newman are not altered by RNase Y deletion ([@B11]) and, therefore, the difference in *saeR* levels between the wild-type and the *rny* mutant are attributable solely to altered RNA processing. As shown in Figure [1D](#F1){ref-type="fig"}, the ratio between *saeR* and *saeP* was lower in the *rny* mutant compared with the wild-type. This effect could also be complemented by ectopic expression of RNase Y. In this strain the *saeR/saeS* ratio is even higher than the wild-type, in accordance with excess RNase Y by ectopic expression. Thus, RNase Y allows differential expression between genes that are co-expressed in the *saePQRS* operon, shifting the balance towards *saeRS*.

An active form of RNase Y is required for *sae* processing {#SEC3-2}
----------------------------------------------------------

RNase Y in *B. subtilis* is thought to act as a scaffold for the formation of a protein complex resembling the *E. coli* degradosome ([@B9],[@B22],[@B23],[@B25]); the presence of a similar degradosome-like complex has also been suggested for *S. aureus* ([@B24]). Thus, it is feasible that RNase Y may not directly cleave the *sae* transcript but rather recruits other proteins responsible for this cleavage (e.g. RNase J1). To address this question, active site mutants of RNase Y were analyzed in a complementation assay. Plasmids with cloned genes coding for full-length RNase Y, truncated RNase Y lacking its active site (ΔAS) or RNase Y with point mutations in His367 and Asp368 that constitute the highly conserved HD motif (367^AA^), were introduced into *rny* mutant strains carrying the artificial *sae-gfp* constructs pCG212 and pCG213. Processing was then analyzed by northern blot analysis using *gfp*-specific probes. Only complementation with full-length, intact RNase Y could restore cleavage (Figure [2A](#F2){ref-type="fig"}, lanes 3 and 8).

![*sae* processing requires an active RNase Y. Wild-type, *rny* mutant, complemented strain with truncated RNase Y lacking its active site (ΔAS) and complemented strains with RNase Y with point mutations in His367 and Asp368 that constitute the highly conserved HD motif (367^AA^), all carrying the *sae-gfp* constructs indicated in the figure, were grown to exponential phase. RNA was harvested and hybridized to DIG-labeled DNA probes specific for *gfp* or *rny*. As a loading control, 16S rRNA was detected in the ethidium bromide-stained gel, as shown at the bottom of the figure.](gkx296fig2){#F2}

SaeP does not influence RNase Y-dependent processing {#SEC3-3}
----------------------------------------------------

To further define the sequence/structural requirements for RNase Y-dependent cleavage, an additional *sae-gfp* construct carrying just the region encompassing the two stem loops but lacking *saeP* was designed (pCG301) (Figure [3A](#F3){ref-type="fig"}). The construct was integrated into the chromosome of Newman wild-type and *rny* mutant strains, and processing was analyzed by northern blot analysis using a *gfp*-specific probe (Figure [3B](#F3){ref-type="fig"}). RNase Y-dependent processing was still detectable. Thus, upstream sequences lying within the co-transcribed *saeP* gene are dispensable for RNase Y activity.

![RNase Y-dependent cleavage is independent from *saeP* and CS sequences. (**A**) Schematic representation of construct pCG301 carrying just the region of *sae* between the two stem loops under the native promoter P1. Below the construct, the RNAs observed in the northern blot analysis are indicated. (**B**) Northern blot analyses to examine *sae* processing of the pCG301 construct. Newman wild-type and *rny* mutant strains carrying pCG301 were grown to the exponential phase, and RNA was harvested and hybridized to a DIG-labeled DNA probe specific for *gfp* and *rny*. The 16S rRNA detected in ethidium bromide-stained gel served as a loading control and is shown at the bottom of the panel. (**C**) Northern blot analyses to examine *sae* processing in strains carrying the *sae-gfp* constructs shown in Figure [1B](#F1){ref-type="fig"}. Newman wild-type and *rny* mutant strains carrying the different constructs were grown to exponential phase. RNA was then harvested and hybridized to DIG-labeled DNA probes specific for *gfp, saeP* and *rny*. As a loading control, 16S rRNA was detected in ethidium bromide-stained gel, as shown at the bottom of the panel. (**D**) Mapping of the 5΄ end of the processed RNA in construct pCG213 by RACE analyses. cDNA was obtained using RNA from the Newman wild-type strain carrying pCG213. The *sae* sequence shown in the panel is aligned with those of three different clones (1, 2 and 3). The RNA 5΄ adapter is underlined, and the mapped position for the alternative cleavage site (aCS) is indicated in bold. The deletion in construct pCG213 and the shift of the CS are also shown.](gkx296fig3){#F3}

The results shown in Figure [1](#F1){ref-type="fig"} were obtained in a strain in which *saeP* was deleted. In order to rule out any possible interference of SaeP deletion with our previous conclusions, the *sae-gfp* constructs were also analyzed in Newman wild-type background, providing essentially the same results (compare Figures [1C](#F1){ref-type="fig"} and [3C](#F3){ref-type="fig"}): in the wild-type strains, processing was indicated by two bands, whereas only the unprocessed transcript was detectable in the *rny* mutant. Only a large deletion encompassing the CS (construct pCG223) prevented cleavage.

RNase Y cleavage is not determined by the CS sequence {#SEC3-4}
-----------------------------------------------------

Interestingly, the deletion of 13 bp encompassing the cleavage site (construct pCG213) did not prevent cleavage by RNase Y (Figures [1C](#F1){ref-type="fig"} and [3C](#F3){ref-type="fig"}). Next, we mapped the cleavage site in construct pCG213 by 5΄ RACE (Figure [3D](#F3){ref-type="fig"}). Sequencing of various clones revealed the cleavage sites all mapped to the same position, allowing the detection of what we called an 'alternative cleavage site (aCS)'. The aCS mapped precisely 13 nt upstream of the native CS ([@B11]). Interestingly, the deletion in construct pCG213 was also 13 nt long, suggesting that RNase Y may recognize a specific sequence/structure downstream of CS and cleave at a specific distance.

To further investigate this hypothesis, two additional constructs were designed (Figure [4A](#F4){ref-type="fig"}). Construct pCG392 carries a 24-bp deletion downstream of CS, whereas construct pCG394 carries a deletion of both CS and aCS. These two constructs were integrated into the chromosome of Newman wild-type and *rny* mutant strains and analyzed by northern blot analysis using a *gfp*-specific probe. The reference construct pCG212 was included in the analysis as a control.

![RNase Y-dependent cleavage occurs 6 nt upstream of putative recognition determinant. (**A**) Schematic representation of constructs pCG392 and pCG394 carrying a deletion downstream of CS and a deletion of both aCS and CS, respectively (deletions are indicated in the panel as a cross). The RNAs detected in the northern blot analysis are shown below each construct. (**B**) Northern blot analyses to examine *sae* processing in strains carrying pCG392 and pCG394. Newman wild-type and *rny* mutant strains carrying the different constructs were grown to exponential phase (Newman pCG212 was included in the analysis as a control). RNA was then harvested and hybridized to DIG-labeled DNA probes specific for *gfp* and *rny*. As a loading control, 16S rRNA was detected in the ethidium bromide-stained gel, as shown at the bottom of the panel. The processed RNA found in construct pCG394 is indicated by \*. (**C**) Mapping of the 5΄ end of the processed RNA in construct pCG394. The *sae* sequence is aligned with those of three different clones ([@B1], [@B2] and [@B3]). The RNA 5΄ adapter is underlined, and the mapped position for alternative cleavage site 2 (aCS2) is shown in bold. The deletion in construct pCG394 and the shift in the CS are also indicated. (**D**) The RNase Y recognition sequence (Rrs) is underlined; the distance between Rrs and the cleavage sites (CS, aCS or aCS2) is underlined with dots.](gkx296fig4){#F4}

Cleavage still occurred in construct pCG394, and a band corresponding to the processed RNA was indeed visible in the wild-type strain (indicated in the image by an asterisk). To further investigate this cleavage, we performed 5΄ RACE analysis. Various clones were sequenced and all mapped to the same position (Figure [4C](#F4){ref-type="fig"}), allowing the detection of another alterative cleavage site (aCS2) exactly 20 nt upstream of the standard CS. The deletion in construct pCG394 was also 20 nt long.

Double strand structure downstream of CS {#SEC3-5}
----------------------------------------

In construct pCG392 (carrying a 24-bp deletion downstream of CS), cleavage no longer occurred (Figure [4B](#F4){ref-type="fig"}), indicating that RNase Y requires a sequence or structure (underlined in Figure [4D](#F4){ref-type="fig"}, tentatively named 'RNase Y recognition sequence, Rrs') located downstream of CS to cleave at a specific distance upstream. To gain further insights into RNase Y requirements, the secondary structure of the region downstream of CS was predicted using mfold software ([@B38]). We found that in all constructs in which processing could still occur (i.e. pCG212, pCG213, Figure [5](#F5){ref-type="fig"} or pCG218, pCG219 and pCG379, [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}), the Rrs formed a double-strand structure with a specific sequence that we termed 'Rrs counterpart'. This double-stranded structure was not predicted in constructs with impaired processing (i.e. pCG392, Figure [5](#F5){ref-type="fig"}), supporting the possibility that this is the structure recognized by RNase Y.

![Secondary structure downstream of CS. Prediction of secondary structures of *sae-*fragments cloned in pCG212, pCG213, pCG394, pCG392 and pCG408 by the mfold software ([@B38]). In each panel, the schematic representation of the construct is shown together with the predicted secondary structure (CS: cleavage site; aCS1: alternative cleavage site1; aCS2: alternative cleavage site 2; Rrs: RNase Y recognition sequence; Rrs\*: Rrs counterpart). Deletions are indicated by a cross. In the predicted secondary structure, when present, Rrs is encircled with a bold line. For clarity, only the portion of the transcript that is of interest is shown.](gkx296fig5){#F5}

To confirm the importance of the double-strand structure consisting of the Rrs and the Rrs counterpart, we analyzed a new construct (pCG484) carrying a deletion of this Rrs counterpart (Figure [6A](#F6){ref-type="fig"} and [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). As observed in Figure [6B](#F6){ref-type="fig"}, in the wild-type strain carrying pCG484 only one band was visible, which corresponded to the unprocessed transcript. This result indicated that the Rrs counterpart also is necessary for cleavage.

![Double strand structure downstream of CS determines *sae* processing. (**A**) Schematic representation of construct pCG484 carrying a deletion in the Rrs counterpart (Rrs\*, indicated by a white rectangle). The RNAs detected in the northern blot analysis are shown below each construct. (**B**) Northern blot analyses to examine *sae* processing in strains carrying pCG384. Newman wild-type and *rny* mutant strains carrying the different constructs were grown to the exponential phase (strains carrying pCG212 and pCG392 were included in the analysis as controls). RNA was harvested and hybridized to DIG-labeled DNA probes specific for *gfp* and *rny*. As a loading control, 16S rRNA was detected in the ethidium bromide-stained gel, as shown at the bottom of the panel. (**C**) Schematic representation of construct pCG599 (reference construct in replicative vector, equivalent to pCG212), pCG616 (carrying point mutation in CS) and pCG618 (carrying point mutations which affect Rrs secondary structure). The RNAs detected in the northern blot analysis are shown below each construct. (**D**) Northern blot analyses to examine *sae* processing in strains carrying pCG599, pCG616 und pCG618. Newman wild-type carrying the different constructs was grown to exponential phase. RNA was harvested and hybridized to DIG-labeled DNA probes specific for *gfp* and *rny*. As a loading control, 16S rRNA was detected in the ethidium bromide-stained gel, as shown at the bottom of the panel.](gkx296fig6){#F6}

Next, we created construct pCG618 carrying single point mutations that prevent formation of the proposed double-strand structure (Figure [6C](#F6){ref-type="fig"} and [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). This construct was cloned into a replicative vector. As a control, we cloned our reference construct pCG212 (which is an integrative vector) into the same replicative vector, yielding construct pCG599. Both constructs were then transformed into the Newman strain and processing was analyzed by northern blot analysis using a *gfp*-specific probe. As can been seen in Figure [6D](#F6){ref-type="fig"}, cleavage was detectable in construct pCG599 but not in construct pCG618, thus further indicating that disturbing the secondary structure hinders cleavage.

So far, we have shown that cleavage does not depend on a distinct cleavage signature. However, all three determined cleavage sites (CS, aCS1 and aCS2) are characterized by a conserved T. To analyze whether this T is required for cleavage, we substituted it for a C in construct pCG616 (Figure [6C](#F6){ref-type="fig"}) and transformed this into the Newman wild-type strain. As can been seen in Figure [6D](#F6){ref-type="fig"}, the exchange did not prevent cleavage, thus corroborating the hypothesis that RNase Y cleavage is not dependent on a distinct cleavage signature.

Role of RNase J1 for *sae* stabilization/processing {#SEC3-6}
---------------------------------------------------

Cleavage of the *sae* transcript by RNase Y leads to stabilization of the generated downstream product ([@B11]). Thus, it could be hypothesized that the predicted secondary structure, instead of being a recognition site for RNase Y, is involved in protection of the downstream fragment from degradation by RNase J1/J2. In this case, RNA transcripts arising from constructs in which the formation of this structure is hindered (i.e. pCG392 and pCG484) might be unprotected, and not accumulate sufficiently to be detected by our assay. To address this question, we analyzed *sae-gfp* processing in the recently described *rnjA* mutant of strain PR01 ([@B39]). In this strain background the plasmids used so far could not be integrated via transduction or transformation. Therefore, we subcloned the constructs into the replicative vector pCG246.

In PR01 wild-type strain containing the replicative reporter constructs *sae-gfp* processing was similar to strain Newman harboring the integrative constructs: no cleavage was detectable in constructs missing the Rrs (pCG601), the Rrs counterpart (pCG600) or the whole region (pCG620). Surprisingly, in the *rnjA* mutant of PR01, processed fragments were detectable in all constructs. These results would suggest that the secondary structure may have a protective function in avoiding degradation by RNase J1. However, processing could also be detected in construct pCG620 (equivalent to pCG223), in which the whole region encompassing the CS is missing. These results suggest that without RNase J1, the activity of RNase Y is somehow altered, leading to so far unobserved processing events.

Of note, while carrying out our usual controls with the *rny* probe, we found that *rnjA* deletion resulted in an alteration of the *rny* transcript, with the appearance of a highly abundant smaller transcript (Figure [7B](#F7){ref-type="fig"}, panel *rny*).

![Interference of RNase J1 with RNase Y activity. (**A**) Schematic representation of construct pCG601, pCG600 and pCG620, which are the equivalent in replicative plasmid of construct pCG392, pCG484 and pCG223, respectively. (**B**) Northern blot analyses to examine *sae* processing in strains carrying pCG600, pCG601 and pCG620. PR wild-type and *rnjA* mutant strains carrying the different construct were grown to the exponential phase (strains carrying the reference construct pCG599 were included in the analysis as controls). RNA was then harvested and hybridized to DIG-labeled DNA probes specific for *gfp, rny* and *rnjA*. As a loading control, 16S rRNA was detected in the ethidium bromide-stained gel, as shown at the bottom of the panel. (**C**) Northern blot analyses to detect *rny* transcript in PR strains. Newman wild-type and *rny* mutant, PR wild-type and *rnjA* mutant strains were grown to exponential phase. RNA was harvested and hybridized to DIG-labeled DNA probes specific for *rnjA, rny* and *rny* 5΄. As a loading control, 16S rRNA was detected in the ethidium bromide-stained gel, as shown at the bottom of the panel.](gkx296fig7){#F7}

We next analyzed the PR strains (without any constructs) and compared them to the Newman strains by northern blot analysis (Figure [7C](#F7){ref-type="fig"}). Again, in the *rnjA* mutant, a highly abundant smaller transcript of *rny* was detectable. With the use of a *rny* probe covering the 5΄ end of the *rny* transcript, this smaller transcript was no longer detectable (Figure [7C](#F7){ref-type="fig"} panel *rny* 5΄), indicating that the smaller *rny* transcript accumulating in the *rnjA* mutant is missing the 5΄ end. A putative internal start codon and ribosomal binding site can be predicted within this truncated *rny* fragment. Thus, the fragment may encode an N-terminal truncated RNase Y with altered requirements and activity. This assumption is supported by our finding that expression of RNase Y without the N-terminal membrane anchor was not possible in *S. aureus*. Interestingly, purified anchorless RNase Y was shown to elicit high RNA degrading activity toward *in vitro* transcribed *sae-gfp*-RNA with no cleavage specificity ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). However, the interpretation of this data is hindered by some experimental limits, e.g. the molecular ratio of RNase Y versus substrate or other experimental conditions might be highly important for maintaining the specificity. We also cannot rule out that RNA degradation is a least partially due to RNases from *E. coli* which co-purify with RNase Y.

DISCUSSION {#SEC4}
==========

RNase Y allows differential expression of genes that are co-transcribed in the same operon {#SEC4-1}
------------------------------------------------------------------------------------------

SaeR and SaeS are part of a bacterial two-component system with a response regulator and a histidine kinase that control the expression of major virulence genes in *S. aureus* ([@B14]--[@B16]). These two proteins are co-transcribed in the *saePQRS* operon with two additional proteins (SaeP and SaeQ). A total of four overlapping RNAs are transcribed, with the major and more stable transcript being generated by endonucleolytic cleavage of the full length T1 transcript by RNase Y ([@B11],[@B20]). We show that the monocistronic transcript encoding *saeP* is a *de novo* transcript from P1 that ends at the *rho*-independent terminator and does not arise from processing of the full length transcript (Figure [1](#F1){ref-type="fig"}). RNase Y cleavage of the full length T1 transcript leads, on the one hand, to stabilization of the downstream fragment and, on the other, to destabilization of the upstream fragment. Thus, RNase Y allows differential expression between the genes that are co-expressed in the *saePQRS* operon, shifting the balance towards *saeRS* (as confirmed by qRT-PCR, Figure [1D](#F1){ref-type="fig"}). SaeP and SaeQ are important to return the activated *sae* system to its pre-stimulated state ([@B17],[@B19]). Thus, RNase Y cleavage might be important in response to certain stress conditions to modulate activation of the *sae* system to limit *saeP* expression in favor of *saeRS*.

In *B. subtilis*, the current model of RNA decay entails endonucleolytic cleavage by RNase Y followed by 5΄-3΄ exonucleolytic degradation by RNase J1 and PNPase 3΄-5΄ exonucleolytic activity ([@B10],[@B29],[@B30]). The importance of RNase Y processing in operon regulation has also been described in *B. subtilis* for the polycistronic *infC-rpmI-rlpT* ([@B40]) and the *gapA* operons ([@B22]). Nevertheless, RNase Y cleavage in the *infC-rpmI-rlpT* operon is needed for subsequent 5΄-3΄ exonucleolytic degradation of the processed RNA by RNase J1 ([@B40]). This phenomenon differs from the action of RNase Y in the *sae* operon, where the downstream transcript arising from cleavage (T2) is stabilized. This may be a special feature of the *sae* operon, in which the downstream fragment is potentially protected, *e.g*. via RNA secondary structures and/or binding proteins. Stabilization of RNase Y-derived cleavage products has also been observed in other species. In *Streptococcus pyogenes*, RNase Y cleaves a longer *speB* transcript, leading to a shorter, more stable transcript ([@B41]). Recently, *Clostridium perfringens* RNase Y has also been shown to be involved in post-transcriptional stabilization of virulence genes *colA* and *pilA* ([@B42]). Thus, stabilization of RNase Y cleavage products may be more common than previously recognized.

The RNase Y-generated *sae* upstream transcript seems to be rapidly degraded via a 3΄-5΄ exonuclease, presumably PNPase. To compensate for the rapid degradation of *saeP* upon RNase Y cleavage, an internal transcription terminator upstream of the CS ensures the expression of *saeP*.

Role of secondary structure downstream of cleavage site {#SEC4-2}
-------------------------------------------------------

Secondary structure prediction revealed that RNase Y is likely to recognize a double-stranded RNA region that forms between Rrs and its counterpart. Moreover, mutations within Rrs and deletion of the Rrs counterpart also inhibited cleavage. These results indicate that the specificity for cleavage is determined by a downstream secondary structure. Khemici *et al*. ([@B12]) also suggested that adjacent secondary structures are probably crucial for RNase Y specificity as bioinformatics analyses of 99 RNase Y target genes did not reveal any common motif. In *B. subtilis*, RNase Y was shown to cleave within an AU-rich region upstream of a stem loop ([@B8]). Although the authors did not perform a detailed investigation of the deletion that would affect cleavage and, consequently, the part of the sequence that was in fact recognized by RNase Y, the secondary structure identified in their study clearly resembles the structure we describe for *sae*. It would be interesting to delete the cleavage site identified by the authors in the *yitY* leader ([@B8]) to confirm our hypothesis that RNase Y recognizes a structure downstream of the site that is then cleaved.

The elucidated secondary structure may also be involved in protection and RNA fragments stabilization. Indeed, in the strain lacking RNase J1, processed transcripts were detected, indicating that the structure protects against RNase J1. However, in the RNase J1 mutant, RNase Y activity presumably is altered, hampering the final interpretation of the results.

RNase Y cleavage is not determined by the cleavage site {#SEC4-3}
-------------------------------------------------------

Deletion of 13 nt encompassing the cleavage site of the *sae* operon did not prevent cleavage (Figures [1C](#F1){ref-type="fig"} and [3C](#F3){ref-type="fig"}). Alternative cleavage sites were detectable 6 nt upstream of a proposed recognition site (Figure [4D](#F4){ref-type="fig"}). Interestingly, the endonucleolytic activity of RNase E also requires the recognition of a region that is adjacent to, but not contiguous with, a segment in which cleavage can occur ([@B43],[@B44]). RNase E favors binding to unpaired neighboring regions, whereas RNase Y appears to prefer the double-stranded sequence.

In both cases, cleavage occurs within a single-stranded stretch. RNase Y cleavage also seems to occur via a ruler-and-cut mechanism. Such a mechanism was recently elucidated for *Salmonella* RNase E enzyme ([@B45]). However, our results indicate that RNase Y in *S. aureus* may use a longer ruler of probably 6 nt. The lack of any structural data for RNase Y means that the molecular mechanism remains unsolved.
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